|
|
||||||||
Clinical Chemistry, Vol 18, 275-279, Copyright © 1972 by the American Association for Clinical Chemistry
1 Cardiac Surgery Unit and the Department of Biochemistry, Royal Infirmary, Glasgow, U.K.
Hydroxypyruvate has been shown to be an alternative substrate for lactate dehydrogenase. The clinical value of this "glycerate dehydrogenase" has
been investigated on 60 patients admitted to the
hospital with a provisional diagnosis of myocardial
infarction. For comparison, lactate dehydrogenase,
-hydroxybutyric dehydrogenase, creatine
kinase, aspartate transaminase, and alanine
transaminase were also assayed at 37°C. Normal
ranges and methods of assay are given for each
enzyme. Glycerate dehydrogenase has greater
activity than any other enzyme and parallels lactate dehydrogenase and
-hydroxybutyric dehydrogenase in its time of peak activity and duration
of increased activity. Clinical and biochemical evidence is provided to show that
-hydroxybutyric
dehydrogenase is not specific for the cardiac isoenzymes. Of the enzymes studied, creatine kinase
activity increases most quickly after myocardial
infarction, and an exclusive role for its use in
coronary care units is also suggested.
-hydroxybutyric dehydrogenase creatine kinase aspartate transaminase glutamic-oxaloacetate transaminase alanine transaminase infarction normal
values ischemia diagnostic aid isoenzyme specificity
Submitted on November 17, 1971
Accepted on December 14, 1971
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |